Losartan
Formulations: - Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet Indications: - Essential hypertension - Heart failure Source: EML workbook import

Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
Formulations: - Oral > Solid: 25 mg tablet; 50 mg tablet; 100 mg tablet Indications: - Essential hypertension - Heart failure Source: EML workbook import
Formulations: - Oral > Solid: 250 mg Indications: - Essential hypertension - Gestational hypertension Source: EML workbook import
Formulations: - Oral > Solid > dosage form: 5 mg (arginine) + 5 mg + 1.25 mg; 5 mg (arginine) + 10 mg + 1.25 mg; 10 mg (arginine) + 5 mg + 2.5 mg; 10 mg (arginine) + 10 mg + 2.5 mg Indications: - Essential hypertension Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 50 mg in ampoule powder for infusion Indications: - Hypertensive crisis Source: EML workbook import
Formulations: - Oral > Solid: 40 mg + 5 mg; 80 mg + 5 mg; 80 mg + 10 mg Indications: - Essential hypertension Source: EML workbook import
Formulations: - Oral > Solid: 40 mg + 12.5 mg; 80 mg + 12.5 mg; 80 mg + 25 mg Indications: - Essential hypertension Source: EML workbook import
Formulations: - Oral > Solid > dosage form: 160 mg + 5 mg + 12.5 mg; 160 mg + 5 mg + 25 mg; 160 mg + 10 mg + 12.5 mg; 160 mg + 10 mg + 25 mg; 320 mg + 10 mg + 25 mg Indications: - Essential hypertension Source: EML workbook import
Formulations: - Oral > Solid: 500 mg Parenteral > General injections > unspecified: 250 mg in 4 mL ampoule (sodium salt) - Oral > Solid: 500 mg Indications: - Bacterial infection of unspecified site - Toxoplasmosis Source: EML workbook import
Indications: - Crohn disease site - Ulcerative colitis Source: EML workbook import
Formulations: - Oral > Solid: 500 mg Local > Rectal > Suppository: 500 mg Local > Rectal > Retention enema: 3 g per 100 mL - Oral > Solid: 500 mg Indications: - Crohn disease site - Ulcerative colitis - Rheumatoid arthritis, serology unspecified Source: EML workbook import
Formulations: - Parenteral > General injections > IM: 1.5 g per 5 mL in 5 mL ampoule Indications: - Visceral leishmaniasis - Mucocutaneous leishmaniasis - Cutaneous leishmaniasis Source: EML workbook import
Formulations: - Oral > Solid: 10 mg; 50 mg Indications: - Visceral leishmaniasis - Cutaneous leishmaniasis - Mucocutaneous leishmaniasis Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.